Funder
Agence Nationale de Sécurité du Médicament et des Produits de Santé
Reference65 articles.
1. EAU guidelines: prostate cancer. Uroweb;Mottet,2020
2. Commission de la transparence_Avis_16 mai 2018_ abiraterone (Zytiga®);HAS,2018
3. Commission de la transparence_Avis_12 juin 2019_Enzalutamide (Xtandi®);HAS,2019
4. Enzalutamide, an oral androgen receptor inhibitor for treatment of castration-resistant prostate cancer;Sternberg;Future Oncol,2019
5. Abiraterone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of “real-life” studies;Marchioni;Ther Adv Urol,2018
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献